.jpg)
Cushman & Wakefield, Inc. announced today that a growing biotech firm, OSI Pharmaceuticals,
Inc., has acquired Ardsley Park Science & Technology Center, the 43-acre former Purdue
Pharma campus in the Town of Greenburgh's Ardsley section. The Westchester County site will
serve as the company's new headquarters, with operations consolidated from locations in
Melville and Farmingdale, N.Y.; Cedar Knolls, N.J.; and Boulder, CO.
Cushman & Wakefield's Tom Giannone, Chris Kinum, Ron Ganter and John Cahill - all
members of the firm's Global Life Science Practice Group based in East Rutherford, N.J. -
represented Purdue Pharma in the $27 million sale, along with Andrew Merin, David Bernhaut,
Gary Gabriel and Jose Cruz of the firm's East Rutherford-based Metropolitan Area Capital
Markets Group.
Ardsley Park Science & Technology Center, located at 410-460 Saw Mill River Road,
includes 400,000 square feet of existing office, laboratory and manufacturing space, as well as
specialty pharmaceutical installations. The six-building campus originally was built for
Ciba-Geigy in 1956, and that company occupied it through 1995. Purdue Pharma purchased the
property in phases before vacating it in 2005 - at which time the company retained Cushman
& Wakefield to market it.
"This campus benefits from its position within the northern cluster of the regional
biotech corridor that stretches from Westchester County south to West Chester Township in
Pennsylvania," Giannone said. "Still, as with any life sciences property, its highly
specific infrastructure and technical build-out required just the right buyer, and finding the
perfect mid-size biotech company had become increasingly challenging as economic conditions
continued to deteriorate.
"Our partnership with Purdue in marketing this property has been persistent and
consistent in seeking opportunities to present Ardsley Park to qualified buyers," he
added. "Our efforts were rewarded upon meeting with OSI Pharmaceuticals. Despite
significant competition, it became apparent that Ardsley Park met OSI's highly specific
needs."
Cushman & Wakefield's Global Life Science Practice Group brings together brokerage
specialists and consulting partners to address the unique strategic requirements of companies
in the life sciences industry. Members of the group have developed broad expertise in the life
sciences arena, demonstrating an understanding of the industry and its specific needs, how the
industry interacts with government agencies for funding and incentives, and an ability to help
clients identify and implement real estate solutions that support core financial and operating
strategies.
The Metropolitan Area Capital Markets Group specializes exclusively in real estate sales,
joint ventures and financing in Northern New Jersey, Fairfield County, Conn.; and Long Island
and Westchester County, N.Y. The team has completed more than $13.6 billion worth of
transactions since 2000. Over the past four years, this included an average of more than $1.5
billion annually, reaching $2.7 billion in 2007.